Patient and prescriber perspectives on proton pump inhibitor (PPI) use and deprescribing in older adults

Background: Approximately 27% of Medicare beneficiaries 65 years and older are taking a PPI placing them as one of the top prescribed medication class in the U.S. Despite the benefits PPIs provide for millions of patients suffering from gastric acid disorders, these drugs have been associated with serious risks. These risks include but are not limited to, decreased bone density, increased risk for infections increased risk of morbidity and mortality. Despite recent data showing the significant risk for adverse events associated with PPI treatment, use in the United States continues to grow, accounting for more than $11.2 billion annually in prescription costs.
Source: Research in Social and Administrative Pharmacy - Category: Pharmaceuticals Authors: Source Type: research